Global comparator data signal “alarm bells” for UK Government, says APBI
pharmaphorum
JULY 27, 2022
The paper, by a team from Imperial College London, concluded that the FDA gave the go ahead to 95% of the 89 products approved between 2010 and 2019 before EMA, with the Europeans trailing the Americans by a median of 241 days. Between 2012 and 2020, it averaged 3% each year, whereas Spain’s share, for example, had increased from 2.6%
Let's personalize your content